Drug manufacturers challenge emergency insulin law in federal court

[sarisataka]

Drug manufacturers challenge emergency insulin law in federal court

A law that is set to give Minnesotans access to an affordable 30-day supply of insulin is being challenged by a group representing pharmaceutical manufacturers.

The Alec Smith Insulin Affordability Act is set to take effect Wednesday. The law, which Gov. Tim Walz signed earlier this year, allows those who are uninsured, under-insured or on Medicare to receive a 30-day supply of insulin for $35. 

A day before the law went into effect, the Pharmaceutical Research and Manufacturers of America, also known as PhRMA, filed a lawsuit in federal court claiming the law is unconstitutional. 

The lawsuit claims that because the law requires drug manufacturers to provide insulin at a reduced price — without any compensation from the state in return — it violates their Fifth and 14th amendment rights, which prohibit the state from taking private property for public use without just compensation

https://kstp.com/health/alec-smith-emergency-insulin-act-phrma-federal-lawsuit/5778079/?cat=1

I wonder if PhRMA will address how insulin prices have more than tripled in recent years. Surely they can explain why insulin in the US costs 10x as much as the same sold in Canada.

[Nature Man]

1. Next, they will claim drugs are people

[HelpImSurrounded]

2. Dismantle BigPharma

One more reason we need Universal Single Payer healthcare

It's also a reason the radically reform our failing patent system. Our patent system rewards distributors over inventors and does nothing to protect the public.

[Midnightwalk]

3. Higher production costs in the US

Bribing politicians to allow pharmaceutical companies to gouge Americans isn't cheap.

Just kidding. It actually is quite cheap and is only a tiny fraction of their increased profits.

[RobinA]

4. They Might Be Right

but how damn scummy. Sometimes right is not the way to be.

[raging moderate]

5. These people are in serious need of some legal restraints on their behavior.

Our pharmaceutical manufacturers have been exhibiting way out of bounds behavior for some time now, and they are only getting worse.